AR070455A1 - Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas - Google Patents

Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas

Info

Publication number
AR070455A1
AR070455A1 ARP090100595A ARP090100595A AR070455A1 AR 070455 A1 AR070455 A1 AR 070455A1 AR P090100595 A ARP090100595 A AR P090100595A AR P090100595 A ARP090100595 A AR P090100595A AR 070455 A1 AR070455 A1 AR 070455A1
Authority
AR
Argentina
Prior art keywords
azatriciclicos
pharmaceutical compositions
bacterial infections
antibiotic compounds
compounds
Prior art date
Application number
ARP090100595A
Other languages
English (en)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR070455A1 publication Critical patent/AR070455A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente se relaciona con compuestos antibacteriales de formula 1 en la cual n es 0 o 1; R1 representa H o F; U representa CH2 o, cuando n es 1, O o NH;ö-ô es un enlace o está ausente; V representa CH o N cuando ö-ô es un enlace, o CH2 o NH cuando ö-ôestá ausente; W representa CH o N; A representa -(CH2)p-NH-(CH2)q- en /// /// donde p es 1 y q es 1 o 2 o, cuando U representa CH2 y n es 1, p también puede ser 0 y q entonces es 2; G representa uno de los grupos de formulas (2) en donde Z representa N o CH y Q representa O o S; y Z0, Z1 y Z2 cada uno representa CH, o Z0 y Z1 cada uno representa CH y Z2 representa N, o Z0 representa CH, Z1 representa N y Z2 representa CH o N, o Z0 representa N y Z1 y Z2 cada uno representa CH; y con sales de tales compuestos.
ARP090100595A 2008-02-20 2009-02-20 Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas AR070455A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008050603 2008-02-20
IB2008054065 2008-10-03

Publications (1)

Publication Number Publication Date
AR070455A1 true AR070455A1 (es) 2010-04-07

Family

ID=40986002

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100595A AR070455A1 (es) 2008-02-20 2009-02-20 Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas

Country Status (14)

Country Link
US (1) US8349828B2 (es)
EP (1) EP2257551B1 (es)
JP (1) JP5349500B2 (es)
KR (1) KR101590202B1 (es)
CN (1) CN102015710B (es)
AR (1) AR070455A1 (es)
AU (1) AU2009215327A1 (es)
BR (1) BRPI0907892A2 (es)
CA (1) CA2713182C (es)
ES (1) ES2411930T3 (es)
MX (1) MX2010008922A (es)
RU (1) RU2010138648A (es)
TW (1) TW200940551A (es)
WO (1) WO2009104147A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009104147A2 (en) 2008-02-20 2009-08-27 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
PT2344495E (pt) * 2008-10-07 2015-04-01 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
EP2346862B1 (en) * 2008-10-10 2012-09-12 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
JPWO2012108376A1 (ja) 2011-02-07 2014-07-03 第一三共株式会社 アミノ基含有ピロリジノン誘導体
EP2726489A1 (en) * 2011-06-30 2014-05-07 DSM IP Assets B.V. Silicone-containing monomer
BR112014003200A2 (pt) 2011-08-11 2017-04-04 Actelion Pharmaceuticals Ltd derivados de quinazolina-2,4-diona
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd 3,7-二取代八氫-2H-吡啶并[4,3-e][1,3]□嗪-2-酮抗生素
WO2014024056A1 (en) 2012-08-06 2014-02-13 Daiichi Sankyo Company, Limited Pyrrolidine derivatives with antibacterial properties
EA029361B1 (ru) 2013-04-16 2018-03-30 Идорсиа Фармасьютиклз Лтд Антибактериальные биароматические производные
ITMI20131782A1 (it) * 2013-10-25 2015-04-26 Dipharma Francis Srl Procedimento per la preparazione di un agonista della trombopoietina
JP6112724B2 (ja) * 2013-10-31 2017-04-12 日本化薬株式会社 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
JP7390728B2 (ja) 2017-11-29 2023-12-04 バグワークス・リサーチ・インコーポレイテッド 抗菌複素環式化合物及びそれらの合成

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746987A (en) * 1980-09-05 1982-03-17 Mitsubishi Chem Ind Ltd 3,4-dihydrocarbostyril derivative and agricultural and horticultural germicide containing the same as active constituent
IT1212552B (it) 1982-10-20 1989-11-30 Italo Britannica L Manet Ti H Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
US5298518A (en) 1989-09-29 1994-03-29 Eisai Co., Ltd. Biphenylmethane derivative and pharmacological use
US5254682A (en) 1989-12-08 1993-10-19 Merck & Co., Inc. Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
EP0934326B1 (de) 1996-10-24 2006-05-03 Novartis AG Substituierte aminoalkanphosphonsäuren
WO2001030782A2 (en) 1999-10-29 2001-05-03 Syngenta Participations Ag Novel herbicides
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
WO2005016883A2 (en) 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
FR2873695A1 (fr) * 2004-07-30 2006-02-03 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
AU2005279050A1 (en) * 2004-07-30 2006-03-09 Centre National De La Recherche Scientifique (Cnrs) Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, and the synthesis and uses thereof as antibacterial agents
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2006032466A2 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
WO2006046552A1 (ja) 2004-10-27 2006-05-04 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
US20090131444A1 (en) 2005-05-24 2009-05-21 Astrazeneca Ab Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
WO2007016610A2 (en) 2005-08-02 2007-02-08 Glaxo Group Limited Antibacterial agents
DE602006012535D1 (de) 2005-10-21 2010-04-08 Glaxo Group Ltd Peri-kondensierte tricyclische verbindungen verwendbar als antibakterielle mittel
ATE465163T1 (de) * 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
CA2642406A1 (en) * 2006-02-14 2007-08-23 Pfizer Products Inc. Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
TW200804336A (en) 2006-03-23 2008-01-16 Actelion Pharmaceuticals Ltd Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
US7709483B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
AU2007259257B8 (en) 2006-06-16 2012-04-05 Pharma Mar, S.A. Antitumoral dihydropyran-2-one compounds
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
ATE495743T1 (de) 2006-12-01 2011-02-15 Galapagos Nv Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
CL2007003693A1 (es) 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
JPWO2008120655A1 (ja) 2007-03-30 2010-07-15 株式会社医薬分子設計研究所 I型11βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
WO2008120003A1 (en) 2007-04-03 2008-10-09 Astrazeneca Ab Substituted piperidines for use in the treatment of bacterial infections
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
EP1980251A1 (en) 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
KR101567096B1 (ko) 2007-04-20 2015-11-06 글락소 그룹 리미티드 항균제로서의 트리시클릭 질소 함유 화합물
GB0707708D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707706D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2154965A4 (en) 2007-05-29 2011-08-17 Glaxosmithkline Llc NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS
AR066879A1 (es) 2007-06-08 2009-09-16 Novartis Ag Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus
MX2009013254A (es) 2007-06-15 2010-01-25 Actelion Pharmaceuticals Ltd Derivados 3-amino-6(1-amino-etil)-tetrahidropirano.
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
MX2010006111A (es) 2007-12-18 2010-06-25 Actelion Pharmaceuticals Ltd Derivados de 5-aminociclilmetil-oxazolidin-2-ona y su uso como antibacteriales.
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds
WO2009104147A2 (en) 2008-02-20 2009-08-27 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
US8349826B2 (en) 2008-02-22 2013-01-08 Actelion Pharmaceuticals Ltd. Oxazolidinone derivatives

Also Published As

Publication number Publication date
KR101590202B1 (ko) 2016-01-29
CN102015710B (zh) 2013-04-24
WO2009104147A3 (en) 2009-11-05
WO2009104147A2 (en) 2009-08-27
US8349828B2 (en) 2013-01-08
CA2713182A1 (en) 2009-08-27
MX2010008922A (es) 2010-09-07
RU2010138648A (ru) 2012-03-27
EP2257551A2 (en) 2010-12-08
US20100331318A1 (en) 2010-12-30
ES2411930T3 (es) 2013-07-09
TW200940551A (en) 2009-10-01
CA2713182C (en) 2016-09-13
JP5349500B2 (ja) 2013-11-20
EP2257551B1 (en) 2013-04-10
JP2011512398A (ja) 2011-04-21
AU2009215327A1 (en) 2009-08-27
BRPI0907892A2 (pt) 2015-07-28
CN102015710A (zh) 2011-04-13
KR20100124273A (ko) 2010-11-26

Similar Documents

Publication Publication Date Title
AR070455A1 (es) Compuestos antibioticos azatriciclicos, composiciones farmaceuticas y su uso para infecciones bacterianas
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
EA201070519A1 (ru) Соединения тропана
CR11861A (es) Compuestos organicos
NO20071880L (no) Diagnostic Compounds
UA112428C2 (uk) Пестицидні композиції і пов'язані з ними способи
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
EA201070786A1 (ru) Бензофуропиримидиноны
UY33921A (es) Oxazinopteridinas y oxazinoptiridinonas n-sustituidas
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
PE20080409A1 (es) Compuestos que modulan en el receptor cb2
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY31933A (es) Compuestos de sulfoximinamida para combatir plagas animales
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
CR10654A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
PA8855001A1 (es) Monocarbamas
CR11859A (es) Composición y proceso-356
ATE478054T1 (de) Benzimidazolderivate
ECSP10010664A (es) Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas
NO20085317L (no) Imidazoazepinonforbindelser
ITMI20051510A1 (it) Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos

Legal Events

Date Code Title Description
FB Suspension of granting procedure